Australia markets open in 8 hours 19 minutes

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.52-0.42 (-7.07%)
As of 11:36AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7787
Avg. Estimate-0.57-0.59-2.38-2.27
Low estimate-0.64-0.66-2.9-3.01
High estimate-0.51-0.52-1.88-1.43
Year ago EPS-0.65-0.71-2.63-2.38
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6676
Avg. Estimate1.4M1.4M4.69M5.13M
Low estimateN/AN/AN/AN/A
High estimate4.4M4.4M17.8M17.8M
Year ago salesN/AN/AN/A4.69M
Sales growth (year/est)N/AN/AN/A9.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.68-0.7-0.72-0.33
Actual EPS-0.65-0.71-0.7-0.58
Difference0.03-0.010.02-0.25
Surprise %4.40%-1.40%2.80%-75.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.57-0.59-2.38-2.27
7 days ago-0.58-0.59-2.4-2.26
30 days ago-0.58-0.59-2.4-2.26
60 days ago-0.64-0.67-2.69-2.38
90 days ago-0.65-0.68-2.63-2.28
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days111N/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesGLUEIndustrySector(s)S&P 500
Current qtr.12.30%N/AN/AN/A
Next qtr.16.90%N/AN/AN/A
Current year9.50%N/AN/AN/A
Next year4.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A